Concepedia

Ralf Oberneder

RO

3

Publications

77

Citations

3

H-Index

1997

Active since

Affiliations

University Hospital Augsburg(Current)

Ralf Oberneder is an author at University Hospital Augsburg specializing in cancer therapeutics, urology, and radiation oncology.

Top concepts

UrologyCancer TherapyMedicineOncologyImmunologyPharmacologyCancer ResearchClinical TrialsPharmacotherapyRadiation Oncology

Publications per year

1997–2011

3

Publications

3

A phase I study with adecatumumab, a human antibody directed against epithelial cell adhesion molecule, in hormone refractory prostate cancer patients

Ralf Oberneder, Dorothea Weckermann, Beatrice Ebner et al. · European Journal of Cancer · 2006 · 55 citations

Urology, Genitourinary Cancer, Human Antibody +5

Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCL.

Nuessler, Scheulen Me, Ralf Oberneder et al. · PubMed · 1997 · 12 citations

A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC).

Albrecht Reichle, Martin Vogelhuber, S. Feyerabend et al. · Journal of Clinical Oncology · 2011 · 10 citations

Urology, Oncology, Psa-response Rate +15

Rows per page

1–3 of 3